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Background. Endovascular repair (ER) of abdominal aortic aneurysm (AAA) is a new technique, and reported rates of
endoleak, conversion to open repair, rupture and mortality vary widely. The aim of this study was to estimate these rates
from the published data, and examine how this has changed as more patients have undergone ER.
Methods. A systematic review and meta-analysis of publications identified through searches of the electronic databases
EMBASE and Medline. All publications quoting endoleak, conversion to open repair, rupture and mortality rates for a
series of patients undergoing ER were included.
Results. 163 studies pertaining to 28,862 patients undergoing ER were identified as relevant for the review and meta-
analysis. The pooled estimate for operative mortality was 3.3% (95% confidence interval 2.9 to 3.6%). The pooled estimate
for type 1 endoleaks was 10.5% (95% confidence interval 9.0 to 12.1%), with an annual rate of 8.4% (95% confidence
interval 5.7% to 12.2%). The pooled estimate of type 2,3 and 4 endoleaks was 13.7% (95% confidence interval 12.3
to15.3%), with an annual rate of 10.2% (95% confidence interval 7.4% to 14.1%). The pooled estimate for primary con-
version to open repair was 3.8% (95% confidence interval 3.2 to 4.4%), and for secondary conversion to open repair 3.4%
(95% confidence interval 2.8 to 4.2%). The pooled estimate for post-operative rupture was 1.3% (95% confidence interval
1.1 to 1.7%), with an annual rupture rate of 0.6% (95% confidence interval 0.5% to 0.8%). Multivariate meta-regression
analysis showed that rates of operative mortality, post-operative rupture and total number of endoleaks all fell significantly
(p< 0.05) over time.
Conclusions. This study demonstrates a low mortality and a gradual reduction in vascular morbidity and mortality
associated with endovascular repair since it was first introduced.
Keywords: Abdominal aortic aneurysm (AAA); Endovascular repair; Meta-analysis.Background
Open surgical repair (OR) is currently the definitive
treatment for abdominal aortic aneurysm (AAA). En-
doaneurysmorraphy with a prosthetic graft was first
described in the literature in 1966,1 and the basic sur-
gical technique has not changed significantly since
then. The mortality rate from elective aneurysm repair
is widely reported to be just below 5%,2 and this has
changed little despite advances in critical care. Ap-
proximately 2/3rds of these deaths are the result of
cardiac morbidity,3 and the need to reduce the physi-
ological insult caused by clamping the aorta has
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aortic aneurysms.
Parodi first published his report on minimally in-
vasive aneurysm surgery in 1991.4 Initial results
were encouraging, and endovascular repair (ER) has
since been employed by many centres worldwide.
This approach is a much less invasive procedure
than OR, and can be successfully performed under
general, regional or local anaesthesia.5
This technique is the first major advance in vascu-
lar surgery since 1966. In the UK over 30 centres took
part in the EVAR Trials 1 and 2. These were rando-
mised controlled trials which assessed ER compared
with OR in patients fit for both types of surgery
(EVAR 1) and ER compared to best medical treatment
in patients who are unfit for OR (EVAR 2). The EVAR
trialists have recently published the results of 4 years
of follow-up of ER patients, which have proved that
the 3% survival advantage conferred by ER at 30rved.
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for OR,6 but in those who are unfit for OR, ER does
not improve survival.7
Meanwhile, many centres performing ER have
published data from case series or case-control series.
The majority of these papers report results from single
centre experience of small numbers of patients with
asymptomatic infrarenal AAA.
The aim of this study was to estimate the operative
mortality, endoleak rate and rate of post-operative
AAA rupture, and quantify how these outcome mea-
sures have changed over time, in patients undergoing
ER. We performed a systematic review, meta-analysis
and meta-regression of the relevant literature. This ar-
ticle was prepared according to previously published
guidelines for reporting meta-analyses8 with some
necessary modifications relating to the specific nature
of synthesis of case series data.
Methods
Search strategy
The lead author (SCF) performed the literature search,
using the Ovid search engine (Version 19.2; Ovid
Technologies Inc NY USA). Both the Medline (January
1966 to August 2003) and EMBASE databases (Janu-
ary 1980 to August 2003) were searched. The follow-
ing search strategies were used on both databases:
1. Exp Aortic Aneurysm, Abdominal (textword) and
exp Stents (textword)
2. Endovascular Surgery (textword) mp and exp Aor-
tic Aneurysm, Abdominal (textword)
3. Exp Aortic Aneurysm, Abdominal (textword) and
Stent Grafts mp
4. Exp Stents and Abdominal Aortic Aneurysm (text-
word) mp
5. Endovascular Surgery (textword) mp and Abdomi-
nal Aortic Aneurysm (textword) mp
6. Stent Grafts (textword) mp and Abdominal Aortic
Aneurysm (textword) mp
7. Medline search strategy to identify randomised
controlled trials from the guidelines of the NHS
centre for reviews and dissemination.9
(Where exp indicates a term explosion e i.e. all sub
categorisations are included in the search, and mp
indicates a multipurpose search).
The search was limited to studies that were in
English and human.
The above searches located studies with and with-
out an abstract available on the database queried. At
this stage, all available abstracts were searched toestablish the relevance of each study and all poten-
tially relevant papers obtained. Those articles remain-
ing that did not have available abstracts were also
retrieved in full. Any articles that were not available
from the University of Leicester libraries were
obtained from the British Library.
Inclusion/Exclusion criteria
All articles included in this study were case series of
a minimum of 5 patients who had undergone ER
and provided data for either mortality or endoleak
rates. Only those studies published in the English lan-
guage were included. Articles were rejected if they
were review articles or letters, if the studies did not
include morbidity or mortality data of a case series
of patients, if the subjects in the study were not
human, or if the subjects did not have degenerative
infrarenal AAA. If the subjects of a study were emer-
gency cases only, the study was excluded from the
analysis. Some studies reported data on both elective
and emergency cases together. Where possible, emer-
gency cases were removed from the analysis, but if
the data sets were amalgamated it was felt better to in-
clude the data on ruptured AAA as numbers were
low and exclusion of these studies would have lead
to loss of valuable outcome data to the meta-analysis.
Some studies had to be excluded because the subjects
did not undergo ER. Studies were excluded if there
was a duplication of data. We used the study centre,
mid-timepoint of the study and size of the study co-
hort to identify duplicated results.
Data extraction
The lead author (SCF) extracted all data. For all studies
included, the total number of patients and the mid-
timepoint of the study were recorded. When the
mid-time point of the study was not given, it was de-
rived from the publication date and length of follow-
up (when available). When given, data on mortality,
morbidity, endoleak and conversion to open repair
were also recorded. Where data were given as a per-
centage, actual numbers were calculated, and the def-
initions used for mortality (‘‘30-day’’, ‘‘in-hospital’’ or
‘‘peri-operative’’) and endoleaks (‘‘proximal’’, ‘‘dis-
tal’’, ‘‘middle’’, ‘‘type I’’, ‘‘type II’’ or ‘‘type III’’) used
by each study were also recorded. When given, endo-
leak rates were also recorded according to the time
they were diagnosed during the post-operative period
(‘‘immediate’’, ‘‘discharge’’, ‘‘1 month’’ or ‘‘late’’). The
number of ER patients who underwent primary (at the
time of the initial operation) or secondary (atEur J Vasc Endovasc Surg Vol 33, February 2007
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were also recorded when given. Any data given per-
taining to post-operative aneurysm rupture and tech-
nical success rates (where technical success was
defined as successful implantation of an endovascular
graft) were also recorded.
Additionally, individual study characteristics per-
ceived as potentially related to the validity and qual-
ity of these particular studies were examined.
Whether each study was a multicentre or single-centre
study and the level of evidence according to the defi-
nitions of Blankensteijn et al.10 were all recorded.
Statistical methods
As studies reported mortality data using a variety of
different definitions, separate meta-analyses were
performed for operative mortality (defined by the
authors as all ‘‘peri-operative’’, ‘‘in hospital’’ and
‘‘30-day’’ mortality), all mortality (‘‘peri-operative’’,
‘‘in hospital’’, ‘‘30-day’’ and ‘‘late’’ mortality associ-
ated with ER), technical success rates, primary and
secondary conversion to open repair, all conversions
to open repair, post-operative rupture and death due
to post-operative rupture.
Binary outcomes were combined on the log odds
scale and then transformed onto the proportions scale
for reporting and interpretation purposes. For inci-
dence rate outcomes, weighted Poisson regression
was used. Heterogeneity between studies was as-
sessed using the chi-squared test, and random effects
models were used for all analyses to incorporate any
heterogeneity present.
Meta-regression analyses (including a random ef-
fect) were also performed on operative mortality, post-
operative rupture and total number of endoleaks, in an
attempt to explain the observed heterogeneity between
study estimates. The effect of time (using the mid-time
point or derived mid-time point), size of study, length
of follow-up, size of aneurysm, average age, geograph-
ical location (Americas¼ 0, Europe¼ 1, Austral-
asia¼ 2, Africa¼ 3) and inclusion criteria (aneurysm
morphologically suitable for ER¼ 1, patient unfit for
OR¼ 2, patient unfit and aneurysm morphology suit-
able for ER¼ 3, patient unfit or aneurysm morphology
suitable for ER¼ 4) were all included individually as
covariates in the meta-regression analyses. We took
a p-value of <0.05 to represent statistical significance.
Sensitivity analysis was performed, stratifying
analyses by the measures of quality identified in the
previous section, to examine whether there was
systematic variation in results across these quality
components. Funnel plots were examined to assess
whether publication bias was likely to be a problem.Eur J Vasc Endovasc Surg Vol 33, February 2007Statistical analyses were carried out using State
Statistical Software, release 8.2 (Stata, College Station,
Texas, USA) and WinBUGS, release 1.4.1 (MRC Bio-
statistics Unit, Cambridge, UK).
Results
Literature search
Database searches located a total of 836 different stud-
ies (not including duplicated search results), 200 of
which did not have an electronic abstract available.
At this stage, all available abstracts were searched to
establish the relevance of each study, and 535 studies
were rejected (Fig. 1). Articles were rejected if they
were case reports, review articles or letters (n¼ 228);
or if the studies did not include either endoleak or
mortality data of (n¼ 182); if the subjects in the study
were not human (n¼ 53); if the subjects did not have
degenerative AAA (n¼ 37); if the subjects were emer-
gency cases only (n¼ 11) or if the subjects did not un-
dergo ER (n¼ 24). There remained 200 articles which
did not have abstracts and were retrieved in full, and a
further 101 studies which were retrieved as they
appeared to be relevant from the abstract review.
Any articles that were not available from the Uni-
versity of Leicester libraries were obtained from the
British Library. 298 articles were successfully retrieved
(3 were untraceable) and of these a further 130 articles
were rejected. 64 studies were rejected because they
were case reports, letters or review articles; 49 studies
did not include any endoleak or mortality data and
were also rejected; 2 studies were rejected because
their subjects were not human; 12 studies were not
about ER of infrarenal aortic aneurysms and were
therefore rejected, and a further 8 studies were
rejected because they were found, at this stage, to be
written in languages other than English.
Study characteristics
16111e171 articles were deemed relevant for inclusion
in this review and contained data pertaining to
28,862 patients. Ninety-six articles were Blankensteijn
level 1b (prospective, hospital-based studies), 43 were
level 2b (retrospective hospital-based studies) and the
remaining 22 studies did not specify how data had
been collected.7
One hundred and thirty studies stated the time pe-
riod covered by their report, and the mid-time point
was derived from the publication date and length of
follow-up (when available) for the remaining 31 stud-
ies. Fifteen of these studies did not provide follow-up
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Fig. 1. Flow diagram of results of literature search.data and the mid-timepoint had to be assumed using
the publication date as a guide in these cases. One
hundred and twenty of the studies reported on male:
female ratios and 131 articles provided an average
age for the case series. Ninety-four studies included
information on inclusion criteria. Details of individual
studies are shown in Table A1 (in the Appendix).
One hundred and thirty-four of the studies in-
cluded in the analysis gave information on both
mortality and endoleaks. Sixteen studies only gave
information on mortality and 11 studies only gave in-
formation on endoleak rates. Sixty-eight of the studies
included in the study contained information pertain-
ing to post-operative aortic rupture, and 148 included
conversion to open repair data (see Table A2 in the
Appendix).
Pooled outcome estimates
The overall pooled estimates for mortality, technical
success, rupture, mortality associated with rupture,
conversion to open repair and endoleaks are shown
in Fig. 2. The figures on the right of the diagram are
the overall rates and 95% confidence intervals, and
they are represented graphically on the left of the di-
agram. These data represent the total number of pa-
tients in the data set who suffered from each of the
outcome measures. They do not take length of follow
up into account, which varies between studies.There was statistically significant heterogeneity
between studies (on the log odds scale), for all out-
comes, all tests having p values<0.01 for heterogeneity.
The overall operative mortality (i.e.; any mortality
rates that were recorded as either ‘‘30 day mortality’’;
‘‘in hospital mortality’’ or ‘‘peri-operative mortality’’)
was 3.3% (95% confidence interval 2.9% to 3.6%).
1.3% of those patients who survived the operation
went on to suffer post-operative rupture of their
AAA (95% confidence interval 1.1% to 1.7%); and
44.4% of these patients died (95% confidence interval
35.6% to 53.6%). 10.5% of patients developed a type 1
endoleak at some time in the post-operative period
(95% confidence interval 9.0% to 12.1%); and the over-
all rate of conversion to open repair (at either initial op-
eration or subsequently) was 5.4% (95% confidence
interval 3.1% to 4.0%).
Fig. 3 shows the annual rates of endoleak and post-
operative ruptures. These data are derived using the
length of follow-up of each study to obtain an annual
rate for endoleaks and post-operative rupture. We did
this analysis because overall estimates for outcomes
such as post-operative rupture and endoleak, which
can occur at any time during the post-operative pe-
riod, do not account for the fact that individual stud-
ies have different lengths of follow-up in the data set.
Every year, 8.4% of patients developed a new type
1 endoleak (95% confidence interval 5.7% to 12.2%),
10.2% developed a new type 2,3 or 4 endoleak (95%
confidence interval 7.4% to 14.1%) and the annualEur J Vasc Endovasc Surg Vol 33, February 2007
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Fig. 2. Pooled outcome estimates. Proportion of the patient cohort who suffered from one episode of each outcome.rate of post-operative rupture was 0.6% (95% confi-
dence interval 0.5% to 0.8%).
Meta-regression analysis
Meta regression was performed as stated in the
methods section. The p-values for significance of
each of the factors for each outcome are presented in
Table 1 (Coefficients for intercepts for each regression
Annual rate (%) (ln scale)
0.5 1.0 5.0 10.0 25.0
Pooled Estimate
(%)
& (95% CI)
Outcome
0.65 (0.48 to 0.84)
8.4 (5.7 to 12.2)
10.2 (7.4 to 14.1)
Post-operative
rupture
Type 1
endoleak
Type 2, 3 & 4
endoleak
Fig. 3.Meta regression of endoleaks and post-operative rup-
tures. Calculation of annual rates of endoleaks and aneu-
rysm rupture.Eur J Vasc Endovasc Surg Vol 33, February 2007equation are not presented for the sake of brevity but
are available from the first author on request). In our
meta-regression analysis we investigated changes in
mortality, rupture and endoleak rates occurring over
time, with study size, AAA size, average age of pa-
tients in the study, worldwide location of the study
and criteria for inclusion in the study. The only factor
that had a statistically significant effect at the 5% level
across all three outcomes was the mid-timepoint of
the study.
Figs. 4e6 show how the annual rates of operative
mortality, rupture and endoleak have fallen between
1992 and 2002. Studies are weighted according to
size and length of follow-up. It is clear from these
diagrams that a few of the larger case series exert
a greater influence over the outcome of the meta-
regression analysis.
Table 1. Meta regression analysis. Analysis of whether or not
study setting variables have a statistically significant effect on
the outcome measures of mortality, post-operative rupture rate
and endoleak rate
Mortality
rate ( p-value)
Rupture
rate ( p-value)
Endoleak
rate ( p-value)
Study mid-timepoint <0.001 <0.001 0.001
Study size 0.128 <0.001 0.106
Length of follow up 0.080 0.003 0.527
Average AAA size 0.035 0.089 0.034
Average age 0.076 0.065 0.908
Location of study 0.007 0.107 0.649
Inclusion criteria 0.207 0.499 0.883
159Systematic Review and Meta-analysis of 12 Years of Endovascular AAA RepairAssessment of study quality
One hundred and thirteen studies were reported as
Blankensteijn level 1b and 39 were Blankensteijn level
2b. There was no information on how data was col-
lected in the remaining 10 studies. Little difference
was observed between all mortality between the 2
types of study (3.4% (95% confidence interval 2.8%
to 4.1%) versus 3.5% (95% confidence interval 2.9%
to 4.1%)).
Assessment of bias
Funnel plots of operative mortality, rupture rate and
endoleak rates were constructed in order to assess
the degree of publication bias. Bias is represented by
asymmetry around the vertical axis of the plot. It is
clear from Figs. 7e9 that there is a large degree of
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Fig. 4. Mortality rate over time. Circles represent individual
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Fig. 5. Rupture rate over time.heterogeneity in this data set, as the points represent-
ing individual studies are not converging to a point at
the axis of the plot. Individual points tend to ‘‘line
up’’ further away from the axis due to sparse data
and single events in some of the studies included in
the data set.
Discussion
The data set analysed in this study has yielded an
operative mortality estimate of 3.3% following endo-
vascular aneurysm repair. The rupture estimate was
1.3%, and 10.5% of patients developed a type 1 endo-
leak after this kind of surgery. This study also demon-
strates that the rates of the above outcomes have all
fallen in first decade since ER was introduced. Mortal-
ity rates in 1992 can be estimated from the regression
line in Fig. 4 as approximately 7.5%, but by 2002 had
fallen to approximately 1.4%. The regression line in
Fig. 5 gives an estimate for rupture rate as 5.0% in
1992 and 0.4% in 2002. Using the regression line
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Fig. 6. Endoleak rate over time.
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160 S. C. Franks et al.from Fig. 6 the endoleak rate can be estimated as 43%
in 1992 and 13.5% in 2002.
This rate of improvement over time is unlikely to
continue, as this would imply that the operative mor-
tality from ER could eventually reach zero. It is much
more likely that future figures would have a less steep
regression line. It is not possible to predict how low
mortality and post-operative complication rates will
fall from these regression lines.
The literature search performed traced a large
number of case series, case reports and letters, each
containing data on a small number of patients. It was
not possible to have two authors performing the data
extraction as the number of studies included in the
meta-analysiswas so large.However, any questionable
studies or data was discussed between the co-authors
for a consensus decision. Studies were excluded if
there were fewer than five patients involved, and as
a result some data may have been lost to the meta-
analysis. However, the inclusion of these smaller pub-
lications may have increased the possibility that data
was repeated, and as letters and case reports are low
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Fig. 9. Funnel plot with pseudo 95% confidence.Eur J Vasc Endovasc Surg Vol 33, February 2007level evidence it was felt prudent to exclude them
from the analysis. Identification of duplicated data
was harder. We compared study centre, mid-timepoint
of study and the size of each data set in an attempt to
identify any data that had been published more than
once. Some studies were excluded, but it was not pos-
sible to completely rule out the possibility that results
had been published more than once.
Meta regression analysis of study size, length of
follow up, average AAA size, average age, study
location and inclusion criteria found no consistent sta-
tistically significant association with the three main
outcomes (operative mortality, rupture rate and endo-
leak rate). However, inadequate statistical power
cannot be ruled out as a reason for the lack of associ-
ations, as data on these study characteristics was often
missing from the publications included.
This meta-analysis reports on data from 28,862 pa-
tients- the largest analysis of its kind in the published
literature. Our meta-regression techniques have also
provided an analysis of trends in post-operative com-
plications and morbidity since ER was introduced.
These statistical techniques have not, to our knowl-
edge, been applied to such a large data set of this
type until now.
The estimates for operative mortality and endoleak
rates are higher than the recently published EVAR
trial14 year results6,7 and a recently published system-
atic review, which analysed data from 19,804 patients
undergoing ER between January 2000 and September
2004.172 These differences may be a result of the fact
that this analysis includes studies which contained
data from early experience of ER, when equipment
was new, clinicians were less experienced (there is
a recognised learning curve associated with ER171),
and exclusion criteria for ER were not clearly estab-
lished. Twenty-nine of the studies in this data set
used unfitness for OR as an inclusion criteria for their
studies.
Assessment of study quality is difficult when per-
forming a meta-analysis of case series. The results of
pooled outcome estimates of the 2 subgroups of level
of evidence are difficult to interpret in this case as
there is an uneven spread of studies across the 2
groups (113 level 1b versus 39 level 2b).
The funnel plots clearly demonstrate the large de-
gree of between study heterogeneity in this data set,
and as a result, publication bias is difficult to assess.
The variability in results is likely to be due to 2 fac-
tors. First is the fact that ER is such a new technique
and therefore there are a large number of case series
with small numbers of patients published in the liter-
ature. Secondly, these studies often included results
from those cases that were performed during the
161Systematic Review and Meta-analysis of 12 Years of Endovascular AAA Repairsurgeon’s passage through the established learning
curve for ER.171
It is also possible that some data in this set has been
repeated, as updated case series are published by the
same author or from the same institution. Such results
are very difficult to identify or test for, and therefore
there may be repetition of data in this analysis. As a re-
sult, any changes in mortality and morbidity with the
passage of time will be distorted, as there is a greater
propensity for ‘‘early’’ data to be counted multiple
times.
This study has shown that mortality and complica-
tion rates associated with ER are improving signifi-
cantly over time. It is important that these results
are borne in mind when considering the results of
the large randomised controlled trials currently
underway. As time progresses, techniques and equip-
ment may continue to improve, and any simultaneous
reduction in morbidity and mortality should be con-
sidered when interpreting long-term results from
large studies.
There is a large volume of published literature on
the subject of ER, although these publications tend
to consist of small, single centre case series. Outcome
reporting between these studies was also very vari-
able. Many studies did not describe how their data
had been collected, and definitions for types of endo-
leak were often unclear. The way in which endoleaks
were reported also varied a great deal between stud-
ies, with some centres reporting all the endoleaks
which occurred during the follow-up period and
others only reporting immediate post-operativeendoleaks or type 1 endoleaks. Definitions of types
of endoleak were also variable- especially prior to
the publication of White et al.’s definition of endoleaks
and classifications of types of endoleaks.172e174
The EVAR trialists have recently published the re-
sults of 4 years of follow-up for EVAR trials 1 and 2.
They have proved that the 3% survival advantage
conferred by ER at 30 days is sustained over 4 years
in patients who are fit for OR,6 but in those who are
unfit for OR, ER does not improve survival.7
The DREAM trialists have also published their
long-term results, but the study was not powered,
and ultimately under-recruited by 12%. The 30-day
mortality was similar to EVAR 1, but the p-value
was not significant because of low power. At 2 years
it was decided to look at all cause mortality rather
than AAA mortality, and this showed that there was
no reduction in all cause mortality.175
Conclusions
This study proves that results from ER of AAA are
improving rapidly, and that while this technique is
in its infancy it is impossible to know how low mor-
bidity and mortality rates may ultimately fall. The
authors have demonstrated a definite improvement
in results during the first decade of ER despite
a data set with high heterogeneity due to the nature
of the current evidence base.Appendix
Table A1. Study characteristics
Author Mid-date of study n ER Average age n female Level of evidence Inclusion criteria
Gordon MK 16/07/1994 32 74 1b 2
May J 01/05/1994 108 70 8 2b 2
Berman SS 01/02/2000 9 77.9 1b 4
Hill BB 01/01/2001 79 11 2b
Ingle H 16/12/1998 58 73 0 2b 1
Miahle C 04/04/1995 79 69.5 4 2b 3
Matsumura JS 07/02/1994 68 73 6 2b
Henretta JP 09/08/1997 47 74.4 1b
Colburn MD 01/08/1995 19 2b 1
Arko FR 01/11/1997 70 73.9 2b
Cuypers PH 01/06/1996 64 68 6 1b 1
Kretschmer G 16/10/1995 30 70 2 1b 4
Pfammater T 01/03/1999 66 79 10 1b 3
Parodi JC 16/10/1991 24 1 1b 2
Broeders IAMJ 01/04/1994 26 68 3 1b
Holzenbein TJ 01/03/1996 50 72 4 1b 1
Papazoglou K 01/06/1996 27 74 2 1b 2
Cuypers PH 01/04/1996 899 69 1b 2
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Author Mid-date of study n ER Average age n female Level of evidence Inclusion criteria
Thomas SM 01/06/1997 611 72 2b 3
Sultan S 16/07/1998 36 72 11 1b 2
Blum U 16/11/1995 26 68 0 1b 1
Murphy KD 01/08/1995 9 63.2 0 1b 2
Duda SH 16/04/1996 14
Silberzweig JE 01/03/1995 54 75 2 2
Chuter TAM 16/02/1997 50 2 2
Gorich J 01/04/1997 70 69.2 11 1b
Baum RA 01/05/1999 50 2
Gorich J 01/12/1996 73 69.8 13 1b
Mita T 01/09/1997 49 73.7 12
May J 01/01/1994 28 70.3 2
Chuter TAM 01/01/1996 52 4
Stelter W 01/01/1996 201 69 17 1
Chuter TAM 01/01/1995 57 7 1b
Blum U 01/09/1995 149 67 1b 1
Moore WS 07/01/1994 46 71.6 5 1b 1
Chuter TAM 01/05/1995 41 4 1b
Brewster DC 01/04/1995 30 1
Ouriel K 01/03/1999 703 75 98 1b
Sampram ESK 18/06/2001 703 75 98 2b
Matsumura JS 28/10/2001 235 70 31 2b 1
Greenberg RK 15/09/1999 528 73 63 1b 3
Bush RL 01/02/1997 104 1b 4
May J 16/02/1995 148 70.6 11 2b 1
Becquemin JP 16/01/1997 75 69.6 5 1b 1
Resch T 16/09/1993 81 9 1b
Naslund TC 01/01/2000 34 69.7 1 1b 1
Yusuf SW 01/02/1995 30 72 2b 2
Chavan A 23/08/1998 22 66.8 0 1
Kinney EV 01/11/1998 150 73 34 1b 1
Koskas F 16/03/1997 94 1
Cohnert TU 16/05/1997 37 67.9 1 1b
Parodi JC 16/06/1992 50 73 5 2b 4
Criado FJ 21/06/1999 471 2b 3
Matsumura JS 20/05/1998 29 76 2 1b
Holzenbein TJ 16/01/1997 173 73.2 18 1b 4
May J 16/02/1995 190 72 15 1b
Wolf YG 16/11/1998 189 26 2b 1
Faries PL 16/09/2000 368 75.8 55 2b 2
Brener BJ 13/04/2000 29 69.8 2 1b 1
Schlensak C 16/02/1996 150 69.6 8 1b 1
Carpenter JP 29/01/2001 118 73 8 1b
Coppi G 16/11/1995 66 69 3 1b 1
Schunn CD 16/12/1995 190 68.7 14 1b
Ligush J Jr. 01/09/2000 33 70.4 12 1
Cartes-Zumelzu 01/09/1999 72 74 6 2b 1
de Virgilio C 01/08/1998 229 74.3 1b
Teufelsbauer H 16/05/1997 206 73.4 21 2b 1
Villareal RP 01/10/1998 12 74 4 2b 2
Bolke E 01/01/1998 20 72.1 6 1b
Resch T 16/07/1997 164 70 21 1b
Marek J 16/05/2000 49 69.6 0 1b 1
Hovsepian DM 01/03/2000 144 72 23 1b
Becker GJ 16/08/1997 305 74 24 1b
Haussegger KA 16/01/1997 30 70.5 2 1b 1
Tonnessen BH 01/07/1998 105 73.2 14 1
Amesur NB 01/05/1997 57 72 9 2b
Patterson MA 16/02/1999 41 74 6 1b 1
Alric P 01/10/1994 23 69 2
Ayerdi J 01/03/2000 96 72.6 11 1b
Uflacker R 11/09/1996 10 65.5 1b 1
Kaufman J 04/07/1998 5 76 1b 1
Criado FJ 17/12/1999 240 75.5 24 1b 1
Zarins CK 01/07/1997 1193 1b 2
Kato N 07/07/1996 15 71 2 1b 1
Cao P 01/01/1998 119 69.8 114 1bEur J Vasc Endovasc Surg Vol 33, February 2007
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Author Mid-date of study n ER Average age n female Level of evidence Inclusion criteria
Chuter TAM 01/12/1997 116 75 1b 2
Buth J 01/08/1996 1554 70 133 1b
Zarins CK 01/02/1998 1067 1b 2
Rehring TF 01/02/1998 51 75.2 3
Bove PG 16/07/1999 28 75 6 2b
Abraham CZ 16/02/2000 116 75 6 2b 1
Cao P 16/03/1998 148 69.8 1b 4
Lobato AC 16/01/1998 35 75 6 1b 1
Chaikof EL 16/09/1997 236 1b
Bertrand M 16/09/1998 193 72 11 2b
Howell MH 16/01/2000 215 72 23 1b
May J 16/11/1994 156 2b
Lawrence-Brown 16/10/1996 108 1b
Tutein RP 01/05/1997 104 70.8 7 1b
May J 01/01/1998 243 72 17 1b 1
Moore WS 01/01/1995 100 73.8 20 1b
Zannetti S 16/09/1998 266 70 16 1b 1
Ohki T 26/08/1998 239 76 36 2b
Howell MH 16/04/1998 89 72.7 13 1b
Edwards WH 01/06/1994 11 69.6 1 1b
May J 07/11/1993 12 1b
Nasim A 01/09/1994 10 72 1 1b
Blum U 02/06/1995 154 1b
Resch T 01/08/1997 158 71 18 1b
Yusuf SW 03/09/1993 5 1b 1
Ramaiah VG 16/03/2000 419 74 12 1b
Lobato AC 01/01/1996 277 73 41 1b 1
Aadahl P 01/01/1996 21 67 4 1b 1
Adelman MA 01/01/1995 130 2b
Thompson MM 01/01/1996 25 71 0 2b 1
Nasim A 16/03/1995 29 72 1 1b
Lyden SP 01/03/1998 23 71 1 2b 1
Liewald F 01/11/1997 130 68 13 1b 1
Haulon S 16/11/1998 96 68 1 1b
Laheij RJF 16/03/1997 2863 1b
von Segesser L 24/03/2001 88 69 1b
Albertini JN 01/11/1998 185 13 1b
Scharrer-Palmer 01/03/1998 31 66.1 2 2b
Moore WS 16/04/1993 10 75 1b
Becquemin JP 01/02/1997 73 2b 1
Lundbom J 01/07/1996 100 70 1b 1
May J 01/11/1994 128 71 11 1b 1
Ricco MD 01/05/1999 47 72.2 1 1b
Lee WA 01/07/1998 150 74.7 19 2b 1
Walker SR 01/04/1996 84 76 5 2b
Coppi G 16/12/1994 27 68 2 1b
Du Toit DF 05/10/1997 12 72.5 2 2b 3
Blum U 11/04/2000 295 70 1b 1
Aho PS 01/11/1998 218 1b 1
Vignali C 01/08/1999 64 69.9 2 1b 1
Zarins CK 01/02/1997 190 73 19 1b
Allen BT 01/09/1997 34 1b
Walker SR 16/04/1996 221 72 51 1b 1
Wirthlin DJ 01/07/2000 145 1b
Zarins CK 16/09/1998 149 1b 1
Deaton DH 01/06/1997 28 72 2 1b
Lee AM 18/01/1996 25 73 4 2b 1
Tutein RP 01/05/1997 104 70.8 7 2b 1
Treharne GD 16/05/1996 49 68 7 2b 1
Matsumura JS 31/01/1994 68 73 6 2b 1
Hansman MF 16/12/2001 50 72.5 20 1b
Makaroun MD 01/02/1997 50 72 8
Dorffner R 16/08/1995 28 70 2 2b 1
Ivancev K 01/05/1995 45 73 2b 1
Lobato AC 01/03/1997 50 82 7 2b 1
Lee WA 01/11/1997 67 74 9 4
May J 16/06/1994 121
Arko FR 16/05/1998 153 74.2 26 1b
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Espinosa G 16/06/1999 134 70.7 14 2b 4
Ivancev K 16/03/1995 81 71 9 1b
Broeders IAMJ 01/08/1995 30 69 1b 1
Van Schie GP 01/03/1996 108 78 17 1
Blum U 01/02/1996 228 67
Alric P 16/01/1999 88 72.6 6 2
Pereira AH 16/08/1998 57 70 8 2b
Gordon MK 16/07/1994 32 74 1b
Table A2. Study outcomes
Author Post-op Rupture Conv to open Operative Deaths Type 1 endoleaks Type 234 endoleaks Total endoleaks
Gordon MK 2 2 2 11
May J 0 20 6 13
Berman SS 0
Hill BB 2 13
Ingle H 0 9 6 9 2 11
Miahle C 0 9 7
Matsumura JS 1 19 0 30 5 35
Henretta JP 0 0 0 5
Colburn MD 4 0 5
Arko FR 0 1 0 4 12 16
Cuypers PH 0 3 3 13
Kretschmer G 3 1 15 5 9
Pfammater T 2 1 9 21
Parodi JC 0 0 1 10 11 5
Broeders IAMJ 1 1 5 10
Holzenbein TJ 5 10 0 13
Papazoglou K 2 0 5 8 19
Cuypers PH 0 31 19 295
Thomas SM 6 39 158 137 10
Sultan S 32 2 6
Blum U 2 1 1 5 5
Murphy KD 0 1 4
Duda SH 4 4
Silberzweig JE 0 9 2 2
Chuter TAM 0 0 6
Gorich J 0 21
Baum RA 1 1 13 8 16
Gorich J 1 1 9
Mita T 1 3
May J 1 2 0 3 5
Chuter TAM 2 1 5 12
Stelter W 1 13 7 37
Chuter TAM 0 4 14 21 16 7
Blum U 2 1 20
Moore WS 4 0 8 12 17
Chuter TAM 0 9 2 15 2 11
Brewster DC 2 10 0 9 2 7
Ouriel K 1 3 12 1 6 151
Sampram ESK 3 13 12 21 130 162
Matsumura JS 3 12 1 28
Greenberg RK 3 48 7 21 86
Bush RL 3 7 13 18
May J 5 4 18
Becquemin JP 2 5 2 27
Resch T 1 0 0 7 20 7
Naslund TC 7 1 3
Yusuf SW 3 2 3
Chavan A 4 1 15
Kinney EV 0 0 5 6
Koskas F 2 2 2 5
Cohnert TU 8 2 3 2 8Eur J Vasc Endovasc Surg Vol 33, February 2007
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Author Post-op Rupture Conv to open Operative Deaths Type 1 endoleaks Type 234 endoleaks Total endoleaks
Parodi JC 0 5 2 6 8
Criado FJ 10 33 8 6
Matsumura JS 0 28
Holzenbein TJ 0 0 5 4 24 56
May J 1 2 8 16 40 37
Wolf YG 2 43
Faries PL 7 43
Brener BJ 2 4 0 10 33 7
Schlensak C 0 0 1 7 3
Carpenter JP 2 22 1 19
Coppi G 0 4 1 11
Schunn CD 5 2 65
Ligush J Jr. 1 31 3 45 20 3
Cartes-Zumelzu 0 1 3 21
de Virgilio C 10 3 18
Teufelsbauer H 5 3
Villareal RP 1 7
Bolke E 0
Resch T 7 43
Marek J 23 1 20 23 18
Hovsepian DM 1 3 16 48
Becker GJ 8 75
Haussegger KA 1 5
Tonnessen BH 3 18
Amesur NB 1 8 0 25 50 21
Patterson MA 2 1 4 1 10
Alric P 1 4 5 9 9 8
Ayerdi J 5 41
Uflacker R 1 1 10 4
Kaufman J 2 10 0 1 7 1
Criado FJ 1 48
Zarins CK 1 22 2 2 166
Kato N 1 14
Cao P 6 0 18
Chuter TAM 15 53 2 15
Buth J 1 40 9 5 346
Zarins CK 4 0 7 11
Rehring TF 1 0 5 10 11
Bove PG 27 0 4
Abraham CZ 9 23 2 16
Cao P 1 17
Lobato AC 1 3 5
Chaikof EL 1 0 10 46
Bertrand M 4 6
Howell MH 1 0 31
May J 7 20
Lawrence-Brown 6 15
Tutein RP 3 2 8 23 8
May J 3 23 8 50
Moore WS 2
Zannetti S 2 3 2 6 20
Ohki T 34 20 38 12 20
Howell MH 12 0 36
Edwards WH 6 0 3 17
May J 2 5 0 7 13 2
Nasim A 2 1 3
Blum U 1 24
Resch T 2 7 2 43
Yusuf SW 2 0 3
Ramaiah VG 3 2 9 15 38
Lobato AC 23 4 20 23
Aadahl P 0 0 1 3
Adelman MA 0 0 5 37
Thompson MM 15 2 4
Nasim A 2 3 4
Lyden SP 1 12 3 12 25
Liewald F 5 2 2 21
Haulon S 7 2 4 65
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Author Post-op Rupture Conv to open Operative Deaths Type 1 endoleaks Type 234 endoleaks Total endoleaks
Laheij RJF 1 85
von Segesser L 6 2 6 15 13
Albertini JN 12 18 47 16
Scharrer-Palmer 16 107 0 7
Moore WS 6 0 4
Becquemin JP 2 2 2 17
Lundbom J 2 16
May J 2 6 4 14
Ricco MD 0 1 0 8 9 15
Lee WA 4 2 59
Walker SR 23 2
Coppi G 3 8 7 4
Du Toit DF 2 0 2
Blum U 1 1 2 2 24
Aho PS 2 7 2 3 1 70
Vignali C 1 20
Zarins CK 3 8 5 70 39
Allen BT 4 1 7
Walker SR 15 88 25
Wirthlin DJ 2 21
Zarins CK 1 2 84
Deaton DH 3 6 0 9
Lee AM 0 4 1 4 17 5
Tutein RP 3 2 8
Treharne GD 0 0 3 2 7
Matsumura JS 3 35
Hansman MF 2 1 8
Makaroun MD 1 17
Dorffner R 19 0 26 9 17
Ivancev K 1 5 1 7 11
Lobato AC 0 3 2 4 13 6
Lee WA 1 2 13 4 34
May J 8 6 7 4 11
Arko FR 4 1
Espinosa G 1 4 9
Ivancev K 1 15 5 14
Broeders IAMJ 1 11
Van Schie GP 1 3 3 6 15
Blum U 1 14 1 21
Alric P 6 4 4 7 11
Pereira AH 3 2 9
Gordon MK 1 5 2 9 12 11
Conv to open¼ all conversions to open AAA repair.References
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